Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas

Background Gross vascular invasion is a well-established prognostic indicator in hepatocellular carcinoma (HCC), but the biological significance of microscopic invasion remains unclear. Methods Curatively resected primary HCCs were classified retrospectively into 3 groups: HCCs without vascular inva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery 2010-03, Vol.147 (3), p.405-414
Hauptverfasser: Tanaka, Shinji, MD, PhD, FACS, Mogushi, Kaoru, PhD, Yasen, Mahmut, MD, PhD, Noguchi, Norio, MD, PhD, Kudo, Atsushi, MD, PhD, Nakamura, Noriaki, MD, PhD, Ito, Koji, MD, PhD, Miki, Yoshio, MD, PhD, Inazawa, Johji, MD, PhD, Tanaka, Hiroshi, PhD, Arii, Shigeki, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 414
container_issue 3
container_start_page 405
container_title Surgery
container_volume 147
creator Tanaka, Shinji, MD, PhD, FACS
Mogushi, Kaoru, PhD
Yasen, Mahmut, MD, PhD
Noguchi, Norio, MD, PhD
Kudo, Atsushi, MD, PhD
Nakamura, Noriaki, MD, PhD
Ito, Koji, MD, PhD
Miki, Yoshio, MD, PhD
Inazawa, Johji, MD, PhD
Tanaka, Hiroshi, PhD
Arii, Shigeki, MD, PhD
description Background Gross vascular invasion is a well-established prognostic indicator in hepatocellular carcinoma (HCC), but the biological significance of microscopic invasion remains unclear. Methods Curatively resected primary HCCs were classified retrospectively into 3 groups: HCCs without vascular invasion (V0), HCCs with microvascular invasion (V1), and HCCs with macrovascular invasion (V2). Microarray profiling of patients with V0, V1, and V2 using Jonckheere-Terpstra (JT) tests and Wilcoxon rank sum tests was performed. Results Distinct patterns of gene expression were demonstrated between V0 and V2 groups; less (L) and highly (H) invasive phenotypes, respectively. It is noteworthy that 2 dendrograms by the hierarchical clustering provided exactly the same assignment results for V1 cases that were thus separated into L and H gene-expression phenotypes. Marked differences were found in overall ( P < .001) and tumor-free survival ( P < .001) between L and H gene-expression phenotypes. Multivariate analyses indicated that the phenotypes of the patterns of gene expression, rather than the clinicopathologic markers of vascular invasion, were independent predictors of tumor recurrence ( P = .031). Using the gene-expression patterns identified by both JT and Wilcoxon rank sum test analyses, other V1 cases validated these differences in tumor-free survivals between gene-expression phenotypes within the group ( P = .039). Conclusion Gene profiling suggested that microvascular invasiveness consisted of a classable mixture of 2 distinct phenotypes. Thus, gene-array analyses may have clinical benefit, because they may in fact be more predictive than other clinical factors.
doi_str_mv 10.1016/j.surg.2009.09.037
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733659124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606009006072</els_id><sourcerecordid>733659124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-e0e8954ac6d1cf0041c54b4884ecc6b9e957b9840e649be86f37d04922bb19b43</originalsourceid><addsrcrecordid>eNp9kUuLFDEQgIMo7uzqH_AgfRFPPVYe_QiIIIu7Cgsi6jmk09Vuxp6kTXUPzr837QwKHoQiCeSrB18x9ozDlgOvX-22tKRvWwGgt2vI5gHb8EqKspE1f8g2AFKXNdRwwS6JdpBBxdvH7IJrrSouYcM-3WLAEn9OCYl8DMV0jyHOxwmpGGIqDpbcMtpU-JCf_pBpoiIOxT1Odo4Ox_H3t7PJ-RD3lp6wR4MdCZ-e7yv29ebdl-v35d3H2w_Xb-9KpxTMJQK2ulLW1T13A4DirlKdaluFztWdRl01nW4VYK10h209yKYHpYXoOq47Ja_Yy1PdKcUfC9Js9p7WeWzAuJBppKwrzcVKihPpUiRKOJgp-b1NR8PBrCbNzqwmzWrSrCGbnPT8XH7p9tj_TTmry8CLM5AV2XFINjhPfzghVCuaqs3c6xOHWcbBYzLkPAaHvU_oZtNH__853vyT7kYffO74HY9Iu7ikkDUbbkgYMJ_Xna8rBw35bIT8Bcv-p9Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733659124</pqid></control><display><type>article</type><title>Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tanaka, Shinji, MD, PhD, FACS ; Mogushi, Kaoru, PhD ; Yasen, Mahmut, MD, PhD ; Noguchi, Norio, MD, PhD ; Kudo, Atsushi, MD, PhD ; Nakamura, Noriaki, MD, PhD ; Ito, Koji, MD, PhD ; Miki, Yoshio, MD, PhD ; Inazawa, Johji, MD, PhD ; Tanaka, Hiroshi, PhD ; Arii, Shigeki, MD, PhD</creator><creatorcontrib>Tanaka, Shinji, MD, PhD, FACS ; Mogushi, Kaoru, PhD ; Yasen, Mahmut, MD, PhD ; Noguchi, Norio, MD, PhD ; Kudo, Atsushi, MD, PhD ; Nakamura, Noriaki, MD, PhD ; Ito, Koji, MD, PhD ; Miki, Yoshio, MD, PhD ; Inazawa, Johji, MD, PhD ; Tanaka, Hiroshi, PhD ; Arii, Shigeki, MD, PhD</creatorcontrib><description>Background Gross vascular invasion is a well-established prognostic indicator in hepatocellular carcinoma (HCC), but the biological significance of microscopic invasion remains unclear. Methods Curatively resected primary HCCs were classified retrospectively into 3 groups: HCCs without vascular invasion (V0), HCCs with microvascular invasion (V1), and HCCs with macrovascular invasion (V2). Microarray profiling of patients with V0, V1, and V2 using Jonckheere-Terpstra (JT) tests and Wilcoxon rank sum tests was performed. Results Distinct patterns of gene expression were demonstrated between V0 and V2 groups; less (L) and highly (H) invasive phenotypes, respectively. It is noteworthy that 2 dendrograms by the hierarchical clustering provided exactly the same assignment results for V1 cases that were thus separated into L and H gene-expression phenotypes. Marked differences were found in overall ( P &lt; .001) and tumor-free survival ( P &lt; .001) between L and H gene-expression phenotypes. Multivariate analyses indicated that the phenotypes of the patterns of gene expression, rather than the clinicopathologic markers of vascular invasion, were independent predictors of tumor recurrence ( P = .031). Using the gene-expression patterns identified by both JT and Wilcoxon rank sum test analyses, other V1 cases validated these differences in tumor-free survivals between gene-expression phenotypes within the group ( P = .039). Conclusion Gene profiling suggested that microvascular invasiveness consisted of a classable mixture of 2 distinct phenotypes. Thus, gene-array analyses may have clinical benefit, because they may in fact be more predictive than other clinical factors.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2009.09.037</identifier><identifier>PMID: 19945130</identifier><identifier>CODEN: SURGAZ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Aged ; Biological and medical sciences ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Cohort Studies ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Profiling ; General aspects ; Hepatectomy ; Hepatic Veins - pathology ; Humans ; Liver Neoplasms - genetics ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Multigene Family ; Neoplasm Invasiveness ; Phenotype ; Portal Vein - pathology ; Retrospective Studies ; Surgery ; Tumors</subject><ispartof>Surgery, 2010-03, Vol.147 (3), p.405-414</ispartof><rights>Mosby, Inc.</rights><rights>2010 Mosby, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2010 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-e0e8954ac6d1cf0041c54b4884ecc6b9e957b9840e649be86f37d04922bb19b43</citedby><cites>FETCH-LOGICAL-c440t-e0e8954ac6d1cf0041c54b4884ecc6b9e957b9840e649be86f37d04922bb19b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039606009006072$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22482758$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19945130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanaka, Shinji, MD, PhD, FACS</creatorcontrib><creatorcontrib>Mogushi, Kaoru, PhD</creatorcontrib><creatorcontrib>Yasen, Mahmut, MD, PhD</creatorcontrib><creatorcontrib>Noguchi, Norio, MD, PhD</creatorcontrib><creatorcontrib>Kudo, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Nakamura, Noriaki, MD, PhD</creatorcontrib><creatorcontrib>Ito, Koji, MD, PhD</creatorcontrib><creatorcontrib>Miki, Yoshio, MD, PhD</creatorcontrib><creatorcontrib>Inazawa, Johji, MD, PhD</creatorcontrib><creatorcontrib>Tanaka, Hiroshi, PhD</creatorcontrib><creatorcontrib>Arii, Shigeki, MD, PhD</creatorcontrib><title>Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Background Gross vascular invasion is a well-established prognostic indicator in hepatocellular carcinoma (HCC), but the biological significance of microscopic invasion remains unclear. Methods Curatively resected primary HCCs were classified retrospectively into 3 groups: HCCs without vascular invasion (V0), HCCs with microvascular invasion (V1), and HCCs with macrovascular invasion (V2). Microarray profiling of patients with V0, V1, and V2 using Jonckheere-Terpstra (JT) tests and Wilcoxon rank sum tests was performed. Results Distinct patterns of gene expression were demonstrated between V0 and V2 groups; less (L) and highly (H) invasive phenotypes, respectively. It is noteworthy that 2 dendrograms by the hierarchical clustering provided exactly the same assignment results for V1 cases that were thus separated into L and H gene-expression phenotypes. Marked differences were found in overall ( P &lt; .001) and tumor-free survival ( P &lt; .001) between L and H gene-expression phenotypes. Multivariate analyses indicated that the phenotypes of the patterns of gene expression, rather than the clinicopathologic markers of vascular invasion, were independent predictors of tumor recurrence ( P = .031). Using the gene-expression patterns identified by both JT and Wilcoxon rank sum test analyses, other V1 cases validated these differences in tumor-free survivals between gene-expression phenotypes within the group ( P = .039). Conclusion Gene profiling suggested that microvascular invasiveness consisted of a classable mixture of 2 distinct phenotypes. Thus, gene-array analyses may have clinical benefit, because they may in fact be more predictive than other clinical factors.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Profiling</subject><subject>General aspects</subject><subject>Hepatectomy</subject><subject>Hepatic Veins - pathology</subject><subject>Humans</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multigene Family</subject><subject>Neoplasm Invasiveness</subject><subject>Phenotype</subject><subject>Portal Vein - pathology</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Tumors</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUuLFDEQgIMo7uzqH_AgfRFPPVYe_QiIIIu7Cgsi6jmk09Vuxp6kTXUPzr837QwKHoQiCeSrB18x9ozDlgOvX-22tKRvWwGgt2vI5gHb8EqKspE1f8g2AFKXNdRwwS6JdpBBxdvH7IJrrSouYcM-3WLAEn9OCYl8DMV0jyHOxwmpGGIqDpbcMtpU-JCf_pBpoiIOxT1Odo4Ox_H3t7PJ-RD3lp6wR4MdCZ-e7yv29ebdl-v35d3H2w_Xb-9KpxTMJQK2ulLW1T13A4DirlKdaluFztWdRl01nW4VYK10h209yKYHpYXoOq47Ja_Yy1PdKcUfC9Js9p7WeWzAuJBppKwrzcVKihPpUiRKOJgp-b1NR8PBrCbNzqwmzWrSrCGbnPT8XH7p9tj_TTmry8CLM5AV2XFINjhPfzghVCuaqs3c6xOHWcbBYzLkPAaHvU_oZtNH__853vyT7kYffO74HY9Iu7ikkDUbbkgYMJ_Xna8rBw35bIT8Bcv-p9Y</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Tanaka, Shinji, MD, PhD, FACS</creator><creator>Mogushi, Kaoru, PhD</creator><creator>Yasen, Mahmut, MD, PhD</creator><creator>Noguchi, Norio, MD, PhD</creator><creator>Kudo, Atsushi, MD, PhD</creator><creator>Nakamura, Noriaki, MD, PhD</creator><creator>Ito, Koji, MD, PhD</creator><creator>Miki, Yoshio, MD, PhD</creator><creator>Inazawa, Johji, MD, PhD</creator><creator>Tanaka, Hiroshi, PhD</creator><creator>Arii, Shigeki, MD, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas</title><author>Tanaka, Shinji, MD, PhD, FACS ; Mogushi, Kaoru, PhD ; Yasen, Mahmut, MD, PhD ; Noguchi, Norio, MD, PhD ; Kudo, Atsushi, MD, PhD ; Nakamura, Noriaki, MD, PhD ; Ito, Koji, MD, PhD ; Miki, Yoshio, MD, PhD ; Inazawa, Johji, MD, PhD ; Tanaka, Hiroshi, PhD ; Arii, Shigeki, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-e0e8954ac6d1cf0041c54b4884ecc6b9e957b9840e649be86f37d04922bb19b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Profiling</topic><topic>General aspects</topic><topic>Hepatectomy</topic><topic>Hepatic Veins - pathology</topic><topic>Humans</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multigene Family</topic><topic>Neoplasm Invasiveness</topic><topic>Phenotype</topic><topic>Portal Vein - pathology</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Shinji, MD, PhD, FACS</creatorcontrib><creatorcontrib>Mogushi, Kaoru, PhD</creatorcontrib><creatorcontrib>Yasen, Mahmut, MD, PhD</creatorcontrib><creatorcontrib>Noguchi, Norio, MD, PhD</creatorcontrib><creatorcontrib>Kudo, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Nakamura, Noriaki, MD, PhD</creatorcontrib><creatorcontrib>Ito, Koji, MD, PhD</creatorcontrib><creatorcontrib>Miki, Yoshio, MD, PhD</creatorcontrib><creatorcontrib>Inazawa, Johji, MD, PhD</creatorcontrib><creatorcontrib>Tanaka, Hiroshi, PhD</creatorcontrib><creatorcontrib>Arii, Shigeki, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Shinji, MD, PhD, FACS</au><au>Mogushi, Kaoru, PhD</au><au>Yasen, Mahmut, MD, PhD</au><au>Noguchi, Norio, MD, PhD</au><au>Kudo, Atsushi, MD, PhD</au><au>Nakamura, Noriaki, MD, PhD</au><au>Ito, Koji, MD, PhD</au><au>Miki, Yoshio, MD, PhD</au><au>Inazawa, Johji, MD, PhD</au><au>Tanaka, Hiroshi, PhD</au><au>Arii, Shigeki, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>147</volume><issue>3</issue><spage>405</spage><epage>414</epage><pages>405-414</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><coden>SURGAZ</coden><abstract>Background Gross vascular invasion is a well-established prognostic indicator in hepatocellular carcinoma (HCC), but the biological significance of microscopic invasion remains unclear. Methods Curatively resected primary HCCs were classified retrospectively into 3 groups: HCCs without vascular invasion (V0), HCCs with microvascular invasion (V1), and HCCs with macrovascular invasion (V2). Microarray profiling of patients with V0, V1, and V2 using Jonckheere-Terpstra (JT) tests and Wilcoxon rank sum tests was performed. Results Distinct patterns of gene expression were demonstrated between V0 and V2 groups; less (L) and highly (H) invasive phenotypes, respectively. It is noteworthy that 2 dendrograms by the hierarchical clustering provided exactly the same assignment results for V1 cases that were thus separated into L and H gene-expression phenotypes. Marked differences were found in overall ( P &lt; .001) and tumor-free survival ( P &lt; .001) between L and H gene-expression phenotypes. Multivariate analyses indicated that the phenotypes of the patterns of gene expression, rather than the clinicopathologic markers of vascular invasion, were independent predictors of tumor recurrence ( P = .031). Using the gene-expression patterns identified by both JT and Wilcoxon rank sum test analyses, other V1 cases validated these differences in tumor-free survivals between gene-expression phenotypes within the group ( P = .039). Conclusion Gene profiling suggested that microvascular invasiveness consisted of a classable mixture of 2 distinct phenotypes. Thus, gene-array analyses may have clinical benefit, because they may in fact be more predictive than other clinical factors.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19945130</pmid><doi>10.1016/j.surg.2009.09.037</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-6060
ispartof Surgery, 2010-03, Vol.147 (3), p.405-414
issn 0039-6060
1532-7361
language eng
recordid cdi_proquest_miscellaneous_733659124
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Biological and medical sciences
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Cohort Studies
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Profiling
General aspects
Hepatectomy
Hepatic Veins - pathology
Humans
Liver Neoplasms - genetics
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Multigene Family
Neoplasm Invasiveness
Phenotype
Portal Vein - pathology
Retrospective Studies
Surgery
Tumors
title Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A13%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene-expression%20phenotypes%20for%20vascular%20invasiveness%20of%20hepatocellular%20carcinomas&rft.jtitle=Surgery&rft.au=Tanaka,%20Shinji,%20MD,%20PhD,%20FACS&rft.date=2010-03-01&rft.volume=147&rft.issue=3&rft.spage=405&rft.epage=414&rft.pages=405-414&rft.issn=0039-6060&rft.eissn=1532-7361&rft.coden=SURGAZ&rft_id=info:doi/10.1016/j.surg.2009.09.037&rft_dat=%3Cproquest_cross%3E733659124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733659124&rft_id=info:pmid/19945130&rft_els_id=S0039606009006072&rfr_iscdi=true